Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

44.33p
   
  • Change Today:
      0.83p
  • 52 Week High: 159.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 0
  • Market Cap: £16.74m

Regulatory News

Grant of Options and PDMR Dealing 04-Jun-2025 07:00 RNS
Result of AGM 02-Jun-2025 13:32 RNS
Non-Executive Director Board Change 02-Jun-2025 07:00 RNS
Director/PDMR Dealing 21-May-2025 07:00 RNS
Arecor Partnership with Skye Bioscience 19-May-2025 07:00 RNS
Director Dealing 14-May-2025 14:37 RNS
Arecor sells rights to non-Ogluo® products 08-May-2025 07:00 RNS
Posting of 2024 Annual Report and Notice of AGM 06-May-2025 16:42 RNS
Grant of Options and PDMR Dealing 23-Apr-2025 07:00 RNS
Final results for 2024 22-Apr-2025 07:00 RNS
Notice of Results 10-Apr-2025 07:00 RNS
Collaboration with global pharmaceutical partner 26-Mar-2025 07:00 RNS
Arecor partnership with biopharmaceutical company 12-Mar-2025 07:00 RNS
Arecor Full Year 2024 Trading Update 03-Feb-2025 07:00 RNS
Orderly Cessation of Tetris Pharma Operations 10-Jan-2025 07:45 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 44.33p
Change Today 0.83p
% Change 1.92 %
52 Week High 159.00
52 Week Low 38.00
Volume 0
Shares Issued 37.76m
Market Cap £16.74m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.59% below the market average47.59% below the market average47.59% below the market average47.59% below the market average47.59% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
91.95% below the market average91.95% below the market average91.95% below the market average91.95% below the market average91.95% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Income Not Available
Growth
42.14% above the market average42.14% above the market average42.14% above the market average42.14% above the market average42.14% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

AREC Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page